Falconi J, Strobel K, Djiane A, Lassus P [Drosophila as a model to study cancer biology]. Bull Cancer. 2024;111(9):880-892. doi:10.1016/j.bulcan.2024.05.005
Quénet F, Carrère S, Sgarbura O [Contribution of intraperitoneal chemotherapy in the treatment of colorectal peritoneal carcinoma. HIPEC, PIPAC, state of the art and future directions]. Bull Cancer. 2024;111(3):285-290. doi:10.1016/j.bulcan.2023.10.006
de Pellegars-Malhortie A, Picque Lasorsa L, Mazard T, Granier F, Prévostel C Why Is Wnt/?-Catenin Not Yet Targeted in Routine Cancer Care?. Pharmaceuticals (Basel). 2024;17(7):949. doi:10.3390/ph17070949
Linares Díaz J, Edwards J, Deleu A-L, Giaj-Levra N, Prisciandaro E, Paesmans M, Berghmans T, Brandão M What Does N2 Lymph Node Involvement Mean for Patients with Non-Small Cell Lung Cancer (NSCLC)?-A Review of Implications for Diagnosis and Treatment. Cancers (Basel). 2024;16(15):2673. doi:10.3390/cancers16152673
El Osmani N, Prévostel C, Picque Lasorsa L, El Harakeh M, Radwan Z, Mawlawi H, El Sabban M, Shirinian M, Dassouki Z Vitamin C enhances co-localization of novel TET1 nuclear bodies with both Cajal and PML bodies in colorectal cancer cells. Epigenetics. 2024;19(1):2337142. doi:10.1080/15592294.2024.2337142
Slaninová V, Heron-Milhavet L, Robin M, Jeanson L, Aissanou A, Kantar D, Tosi D, Bréhélin L, Gongora C, Djiane A The Hippo pathway terminal effector TAZ/WWTR1 mediates oxaliplatin sensitivity in p53 proficient colon cancer cells. BMC Cancer. 2024;24(1):587. doi:10.1186/s12885-024-12316-4
Adenis A, Ghiringhelli F, Gauthier L, Mazard T, Evesque L, Evrard A, Chalbos P, Moussion A, Gourgou S, Ychou M Regorafenib plus FOLFIRINOX as first-line treatment for patients with RAS-mutant metastatic colorectal cancer (FOLFIRINOX-R trial): a dose-escalation study. Cancer Chemother Pharmacol. 2024;94(3):443-452. doi:10.1007/s00280-024-04682-4
Mazard T, Mollevi C, Loyer E, Léger J, Chautard R, Bouché O, Borg C, Armand-Dujardin P, Bleuzen A, Assenat E, Lecomte T Prognostic value of the tumor-to-liver density ratio in patients with metastatic colorectal cancer treated with bevacizumab-based chemotherapy. A post-hoc study of the STIC-AVASTIN trial. Cancer Imaging. 2024;24(1):77. doi:10.1186/s40644-024-00722-7
Sauvageot S, Mollevi C, Thomas Q, Charissoux M, Darlix A, Rigau V, Bauchet L, Quantin X, Pujol J, Boetto J Prognostic impact of the number and total tumor burden of secondary cerebral lesions in patients with resected brain metastases of non-small cell lung cancers. J Neurosurg. 2024;141(1):89-99. doi:10.3171/2023.11.JNS231923
Flecchia C, Auclin E, Alouani E, Mercier M, Hollebecque A, Turpin A, Mazard T, Pernot S, Dutherage M, Cohen R, Borg C, Hautefeuille V, Sclafani F, Ben-Abdelghani M, Aparicio T, Herve C, Perkins G, Heinrich K, Kunzmann V, Gallois C, Guimbaud R, Tougeron D, Taieb J Primary resistance to immunotherapy in patients with a dMMR/MSI metastatic gastrointestinal cancer: who is at risk? An AGEO real-world study. Br J Cancer. 2024;130(3):442-449. doi:10.1038/s41416-023-02524-3
Nicolle R, Canivet C, Palazzo L, Napoléon B, Ayadi M, Pignolet C, Cros J, Gourgou S, Selves J, Torrisani J, Dusetti N, Cordelier P, Buscail L, Bournet B Predictive genomic and transcriptomic analysis on endoscopic ultrasound-guided fine needle aspiration materials from primary pancreatic adenocarcinoma: a prospective multicentre study. EBioMedicine. 2024;109. doi:10.1016/j.ebiom.2024.105373
Kawabata-Iwakawa R, Iwasa N, Satoh K, Colinge J, Shimada M, Takeuchi S, Fujiwara H, Eguchi H, Oishi T, Sugiyama T, Suzuki M, Hasegawa K, Fujiwara K, Nishiyama M Prediction of response to promising first-line chemotherapy in ovarian cancer patients with residual peritoneal tumors: practical biomarkers and robust multiplex models. Int J Clin Oncol. 2024;29(9):1334-1346. doi:10.1007/s10147-024-02552-w
Mirandola A, Kudriavtsev A, Cofre Muñoz C, Navarro R, Macagno M, Daoud S, Sanchez C, Pastor B, Pisareva E, Marin M, Ruiz J, Piris A, Rodriguez A, Gonzalez N, Vivancos A, Quarà V, Mellano A, Borghi F, Corti G, Marchiò C, Sapino A, Bartolini A, Crisafulli G, Bardelli A, Di Maio M, Lossaint G, Frayssinoux F, Crapez E, Ychou M, Soler R, Fenocchio E, Fernandez Calotti P, Mazard T, Vivas C, Elez E, Di Nicolantonio F, Thierry A Post-surgery sequelae unrelated to disease progression and chemotherapy revealed in follow-up of patients with stage III colon cancer. EBioMedicine. 2024;108. doi:10.1016/j.ebiom.2024.105352
Esposito F, Sinquin C, Colliec-Jouault S, Cuenot S, Pugnière M, Ngo G, Traboni S, Zykwinska A, Bedini E Multi-step semi-synthesis, structural characterization and growth factor interaction study of regiochemically sulfated diabolican polysaccharides. Int J Biol Macromol. 2024;260(Pt 1):129483. doi:10.1016/j.ijbiomac.2024.129483
Giroux P, Vialaret J, Kindermans J, Gabelle A, Bauchet L, Hirtz C, Lehmann S, Colinge J Modeling the Simultaneous Dynamics of Proteins in Blood Plasma and the Cerebrospinal Fluid in Human In Vivo. J Proteome Res. 2024;23(7):2408-2418. doi:10.1021/acs.jproteome.4c00059
Thierry A, Salmon D Inflammation-, immunothrombosis,- and autoimmune-feedback loops may lead to persistent neutrophil self-stimulation in long COVID. J Med Virol. 2024;96(8):e29887. doi:10.1002/jmv.29887
Pisareva E, Mirandola A, Sanchez C, Pastor B, Tanos R, Frayssinoux F, Diab-Assaf M, Anker P, Al Amir Dache Z, Thierry A Impact of platelet activation on the release of cell-free mitochondria and circulating mitochondrial DNA. Clin Chim Acta. 2024;553. doi:10.1016/j.cca.2023.117711
Aubert M, Mege D, Ezzedine W, Pocard M, Quenet F, Wernert R, Glehen O, Pirro N Impact of obesity after cytoreductive surgery and intraperitoneal hyperthermic chemotherapy for rare peritoneal malignancies: Paradox of obesity or poor prognostic factor?. Eur J Surg Oncol. 2024;50(9):108507. doi:10.1016/j.ejso.2024.108507
Mairaville C, Broyon M, Maurel M, Chentouf M, Chiavarina B, Turtoi A, Pirot N, Martineau P Identification of monoclonal antibodies from naive antibody phage-display libraries for protein detection in formalin-fixed paraffin-embedded tissues. J Immunol Methods. 2024;532. doi:10.1016/j.jim.2024.113730
Fisher O, Brown C, Esquivel J, Larsen S, Liauw W, Alzahrani N, Morris D, Kepenekian V, Sourrouille I, Tuech J-J, Ceribelli C, Sgarbura O, Alhosni M, Glehen O, Cashin P Hyperthermic intraperitoneal chemotherapy in colorectal cancer. BJS Open. 2024;8(3):zrae017. doi:10.1093/bjsopen/zrae017
Senesse P, Briant J, Boisselier P, Bensadoun R-J, Vinches M, Faravel K Head and neck cancer patients treated with concomitant chemoradiotherapy involving the oral cavity and oropharynx: is another choice possible than prophylactic gastrostomy?. Curr Opin Oncol. 2024;36(3):128-135. doi:10.1097/CCO.0000000000001031
Rigal E, Courot H, Multrier C, Zemiti S, Lambour J, Pugnière M, de Toledo M, Bossis G, Cartron G, Robert B, Martineau P, Fauvel B, Presumey J, Villalba M Generation of non-genetically modified, CAR-like, NK cells. J Immunother Cancer. 2024;12(7):e009070. doi:10.1136/jitc-2024-009070
Rodríguez-Vázquez M, Falconi J, Heron-Milhavet L, Lassus P, Géminard C, Djiane A Fat body glycolysis defects inhibit mTOR and promote distant muscle disorganization through TNF-?/egr and ImpL2 signaling in Drosophila larvae. EMBO Rep. 2024-09-09. doi:10.1038/s44319-024-00241-3
Figarol S, Delahaye C, Gence R, Doussine A, Cerapio J, Brachais M, Tardy C, Béry N, Asslan R, Colinge J, Villemin J-P, Maraver A, Ferrer I, Paz-Ares L, Kessler L, Burrows F, Lajoie-Mazenc I, Dongay V, Morin C, Florent A, Pagano S, Taranchon-Clermont E, Casanova A, Pradines A, Favre G, Calvayrac O Farnesyltransferase inhibition overcomes oncogene-addicted non-small cell lung cancer adaptive resistance to targeted therapies. Nat Commun. 2024;15(1):5345. doi:10.1038/s41467-024-49360-4
Lehmann S, Vialaret J, Gabelle A, Bauchet L, Villemin J-P, Hirtz C, Colinge J Enabling population protein dynamics through Bayesian modeling. Bioinformatics. 2024;40(8):btae484. doi:10.1093/bioinformatics/btae484
Institut de Recherche en Cancérologie de
